مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

142
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

68
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

The Serum Levels of CCL2 and CCL16 Expression in Patients with Irritable Bowel Syndrome

Pages

  9-14

Keywords

IBS 

Abstract

 Background: Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by altered bowel habits and abdominal pain in the absence of a recognizable structural anomaly. The pathogenesis of IBS has been associated with inflammation and the expression of pro-inflammatory chemokines, such as CCL2 and CCL16. Our study aimed to investigate the relationship between the serum levels of CCL2 and CCL16 and IBS. Additionally, we examined how serum levels of these chemokines relate to IBS subtypes. Methods: Patients with IBS diagnosed according to the Rome III criteria participated in this study (n= 96). Healthy individuals with no history of allergic, autoimmune, chronic or active gastrointestinal infectious diseases were used as controls (n= 44). The serum levels of CCL2 and CCL16 was measured via enzymelinked immunosorbent assay (ELISA). Results: A significant decrease in the serum levels of CCL16 and CCL2 was observed in the patients with IBS. Additionally, the serum levels of CCL16 in IBS patients with diarrhea (IBS/fa?page=1&sort=1&ftyp=all&fgrp=all&fyrs=all" target="_blank">D-IBS) was significantly higher than those with the mixed IBS (IBS/fa?page=1&sort=1&ftyp=all&fgrp=all&fyrs=all" target="_blank">M-IBS) subtype. Conclusions: The significant increase in the serum levels of CCL-16 in patients with IBS/fa?page=1&sort=1&ftyp=all&fgrp=all&fyrs=all" target="_blank">D-IBS compared to patients with IBS/fa?page=1&sort=1&ftyp=all&fgrp=all&fyrs=all" target="_blank">M-IBS suggests that CCL-16 may be used as an immunological biomarker to differentiate between these two subtypes.

Multimedia

  • No record.

    • Cites

  • No record.

    • References

  • No record.

    • Cite

    APA: Copy

    Hayatbakhsh, Mohammad Mahdi, Gowhari Shabgah, Arezoo, Pishgouyi, Saeed, TAVAKOL AFSHARI, JALIL, Zeidabadi, Hadi, & MOHAMMADI, MOJGAN. (2019). The Serum Levels of CCL2 and CCL16 Expression in Patients with Irritable Bowel Syndrome. REPORTS OF BIOCHEMISTRY AND MOLECULAR BIOLOGY, 8(1), 9-14. SID. https://sid.ir/paper/754483/en

    Vancouver: Copy

    Hayatbakhsh Mohammad Mahdi, Gowhari Shabgah Arezoo, Pishgouyi Saeed, TAVAKOL AFSHARI JALIL, Zeidabadi Hadi, MOHAMMADI MOJGAN. The Serum Levels of CCL2 and CCL16 Expression in Patients with Irritable Bowel Syndrome. REPORTS OF BIOCHEMISTRY AND MOLECULAR BIOLOGY[Internet]. 2019;8(1):9-14. Available from: https://sid.ir/paper/754483/en

    IEEE: Copy

    Mohammad Mahdi Hayatbakhsh, Arezoo Gowhari Shabgah, Saeed Pishgouyi, JALIL TAVAKOL AFSHARI, Hadi Zeidabadi, and MOJGAN MOHAMMADI, “The Serum Levels of CCL2 and CCL16 Expression in Patients with Irritable Bowel Syndrome,” REPORTS OF BIOCHEMISTRY AND MOLECULAR BIOLOGY, vol. 8, no. 1, pp. 9–14, 2019, [Online]. Available: https://sid.ir/paper/754483/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button